Atovaquone for Treatment of COVID-19
Clinical trial NCT04456153 · COMPLETED
Trial details
- NCT number
- NCT04456153
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-22
- Primary completion
- 2021-01-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.